Iron status, fibroblast growth factor 23 and cardiovascular and kidney outcomes in chronic kidney disease
Guo H, Yang J, Huang J, Xu L, Lv Y, Wang Y, et al
Can I take a break from semaglutide and restart it later
[1] [2] Additional important safety considerations include risk of pancreatitis, gallbladder disease, hypoglycemia (especially when used with insulin or sulfonylureas), and acute kidney injury associated with severe gastrointestinal adverse reactions
La nausea ha colpito il 28,6% dei pazienti trattati con retatrutide 4 mg, il 38,4% con 9 mg e il 42,4% con 12 mg, contro il 14,8% del placebo